Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh · Delayed Price · Currency is BDT 19.30
-0.10 (-0.52%)
At close: Jul 23, 2026
DSE:IBP Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Revenue Revenue Growth | 242.1 | 184.18 | 176.64 | 374.48 | 484.68 | 782.24 |
Revenue Growth | 165.76% | 4.27% | -52.83% | -22.74% | -38.04% | -9.68% |
Gross Profit Gross Profit Growth | 48.41 | 21.02 | 19.85 | 96.56 | 146.93 | 312.94 |
Operating Income Operating Income Growth | -3.86 | -24.06 | -23.76 | 28.68 | 35.8 | 173.3 |
Net Income Net Income Growth | -14.39 | -36.83 | -40.98 | 8.41 | 25.17 | 134.73 |
Earnings Per Share EPS Growth | -0.12 | -0.32 | -0.35 | 0.07 | 0.22 | 1.18 |
EPS Growth | - | - | - | -66.60% | -81.71% | -13.77% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Cash & Investments Cash & Investments Growth | 1.58 | 4.34 | 10.4 | 11.3 | 28.69 | 35.59 |
Total Debt Total Debt Growth | 18.15 | 20 | 24.2 | 43.61 | 75.36 | 84.94 |
Net Cash (Debt) Net Cash Growth | -16.56 | -15.66 | -13.8 | -32.31 | -46.67 | -49.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.14 | -0.13 | -0.12 | -0.28 | -0.40 | -0.43 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 57.38 | 58.45 | 33.77 | 72.95 | 87.28 | 151.02 |
Capital Expenditures CapEx Growth | -0.56 | -0.56 | -10.13 | -30.03 | -39.68 | -200.41 |
Free Cash Flow Free Cash Flow Growth | 56.82 | 57.89 | 23.64 | 42.92 | 47.6 | -49.39 |
Free Cash Flow Growth | 313.01% | 144.90% | -44.92% | -9.84% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Gross Margin | 19.99% | 11.42% | 11.24% | 25.79% | 30.31% | 40.01% |
Operating Margin | -1.59% | -13.06% | -13.45% | 7.66% | 7.39% | 22.15% |
Pretax Margin | -1.81% | -14.03% | -15.80% | 6.56% | 6.54% | 21.65% |
Profit Margin | -5.94% | -20.00% | -23.20% | 2.25% | 5.19% | 17.22% |
FCF Margin | 23.47% | 31.43% | 13.38% | 11.46% | 9.82% | -6.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.015 | 0.015 | 0.010 | - | 0.100 | 0.400 |
Dividend Per Share Growth | 50.00% | 50.00% | - | - | -75.00% | - |
Dividend Yield | 0.08% | 0.11% | 0.07% | - | 0.56% | 2.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 |
PE Ratio | - | - | - | 234.98 | 80.87 | 16.23 |
P/FCF Ratio | 39.47 | 26.30 | 65.38 | 46.03 | 42.77 | - |
PS Ratio | 9.26 | 8.27 | 8.75 | 5.28 | 4.20 | 2.80 |